Skip to main content
Takeda Ventures, Inc. (TVI) is the corporate venture arm of Takeda Pharmaceutical Company Limited (TPC) a world-class pharmaceutical company and the largest in Japan. TVI (formerly Takeda Research Investment, Inc.), was founded in 2001 with the vision to extend Takedaís reach into the Global scientific community and forge strategic relationships that complement and expand internal R&D capabilities. The change in name to Takeda Ventures, Inc. in 2011 reflects an intention to further leverage TVIís venture networks to engage with new scientific and business avenues for Takeda, using strategic venturing to enable staged-entry into new spaces in a fully-informed manner. Our aim is to encourage and support therapeutic innovation in the biopharmaceutical sector, as well as academic centers of excellence, through early stage capital investment and the provision of access to the resources of a multinational pharmaceutical company.